NCT04083235 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 383
- group Id
- BG001
- value
- 387
- group Id
- BG002
- value
- 770
- units
- Participants
- groups
- description
- Participants were treated with irinotecan liposome injection 50 mg/m\^2 followed by oxaliplatin 60 mg/m\^2, followed by LV 400 mg/m\^2 and then 5-FU 2400 mg/m\^2 IV infusion on Days 1 and 15 of each 28-day cycle until disease progression, death, unacceptable study treatment-related toxicity or withdrawal of consent.
- id
- BG000
- title
- NALIRIFOX
- description
- Participants were treated with nab-paclitaxel 125 mg/m\^2 followed by gemcitabine 1000 mg/m\^2 IV on Days 1, 8 and 15 of each 28-day cycle until disease progression, death, unacceptable study treatment-related toxicity or withdrawal of consent.
- id
- BG001
- title
- Nab-paclitaxel+Gemcitabine
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.71
- value
- 62.8
- group Id
- BG001
- spread
- 8.34
- value
- 64.0
- group Id
- BG002
- spread
- 9.06
- value
- 63.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 179
- group Id
- BG001
- value
- 157
- group Id
- BG002
- value
- 336
- title
- Female
- measurements
- group Id
- BG000
- value
- 204
- group Id
- BG001
- value
- 230
- group Id
- BG002
- value
- 434
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 79
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 305
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 633
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 58
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 315
- group Id
- BG001
- value
- 324
- group Id
- BG002
- value
- 639
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 55
- title
- Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 38
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 19
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 13
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- Multiple
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- The Intent-to-Treat (ITT) population consisted of all randomized participants to whom study treatment was assigned by randomization.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 383
- group Id
- BG001
- value
- 387
- group Id
- BG002
- value
- 770
- units
- Participants
- groups
- description
- Participants were treated with irinotecan liposome injection 50 mg/m\^2 followed by oxaliplatin 60 mg/m\^2, followed by LV 400 mg/m\^2 and then 5-FU 2400 mg/m\^2 IV infusion on Days 1 and 15 of each 28-day cycle until disease progression, death, unacceptable study treatment-related toxicity or withdrawal of consent.
- id
- BG000
- title
- NALIRIFOX
- description
- Participants were treated with nab-paclitaxel 125 mg/m\^2 followed by gemcitabine 1000 mg/m\^2 IV on Days 1, 8 and 15 of each 28-day cycle until disease progression, death, unacceptable study treatment-related toxicity or withdrawal of consent.
- id
- BG001
- title
- Nab-paclitaxel+Gemcitabine
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.71
- value
- 62.8
- group Id
- BG001
- spread
- 8.34
- value
- 64.0
- group Id
- BG002
- spread
- 9.06
- value
- 63.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 179
- group Id
- BG001
- value
- 157
- group Id
- BG002
- value
- 336
- title
- Female
- measurements
- group Id
- BG000
- value
- 204
- group Id
- BG001
- value
- 230
- group Id
- BG002
- value
- 434
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 79
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 305
- group Id
- BG001
- value
- 328
- group Id
- BG002
- value
- 633
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 58
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 315
- group Id
- BG001
- value
- 324
- group Id
- BG002
- value
- 639
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 55
- title
- Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 38
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 19
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 13
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- Multiple
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- The Intent-to-Treat (ITT) population consisted of all randomized participants to whom study treatment was assigned by randomization.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle